Contineum Therapeutics In...

NASDAQ: CTNM · Real-Time Price · USD
7.36
0.10 (1.38%)
At close: Aug 15, 2025, 3:59 PM
7.38
0.27%
After-hours: Aug 15, 2025, 04:10 PM EDT

Contineum Therapeutics Class A Common Stock Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a 50M n/a n/a
Cost of Revenue
n/a n/a 329K n/a
Gross Profit
n/a 50M -329K n/a
Operating Income
-50.89M -16.08M -22.72M -28.65M
Interest Income
8.9M 4.61M 761K 77K
Pretax Income
-42.26M 23.17M -24.25M -29M
Net Income
-42.26M 22.72M -24.25M -29M
Selling & General & Admin
12.47M 6.32M 6.63M 6.29M
Research & Development
38.42M 27.6M 16.89M 22.36M
Other Expenses
n/a 32.15M -92K -91K
Operating Expenses
50.89M 66.08M 22.39M 28.65M
Interest Expense
n/a 208K 388K 332K
Selling & Marketing Expenses
n/a n/a 805K n/a
Cost & Expenses
50.89M 66.08M 22.72M 28.65M
Income Tax Expense
n/a 450K n/a 241K
Shares Outstanding (Basic)
19.35M 25.28M 25.13M 25.13M
Shares Outstanding (Diluted)
19.35M 25.28M 25.13M 25.13M
EPS (Basic)
-2.18 0.90 -0.97 -1.15
EPS (Diluted)
-2.18 0.90 -0.97 -1.15
EBITDA
-42M 23.57M -23.54M -28.34M
EBIT
-42.26M 23.38M -23.86M -28.67M
Depreciation & Amortization
258K 195K 329K 325K